Seizures in dogs and cats are often caused by abnormal brain activity. They can be subtle or cause violent convulsions. Some seizures only occur once, but repeated seizures require treatment to prevent larger areas of the brain from becoming affected.
IGC has applied for a U.S patent based on a novel therapy using cannabinoid extracts. The therapy is administered, using a variety of delivery technologies, for indications in mammals such as dogs and cats. The therapy may also be useful in humans. We expect to conduct metabolic profiling and apply to the FDA for trials.